aDepartment of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden bDepartment of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, ...
Phase 1b Trial Reported Approximately 65% Pathological Response in cSCC, Including Complete Responses at Maximum Dose, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results